secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0001156039-23-000106
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health amends bylaws to align with SEC universal proxy rules
---------------------------------------------------------------------

- Shareholders must provide detailed Schedule 13D-type disclosures on plans, agreements with respect to company securities.
- Nominating shareholder must certify compliance with Exchange Act Rule 14a-19 at least 10 days before meeting.
- Shareholders soliciting proxies must use a proxy card color other than white (reserved for Board).
- Number of nominees a shareholder may propose is capped at number of directors to be elected.
- Votes for any nominee not complying with bylaws or Rule 14a-19 may be disregarded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603923000106/0001156039-23-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603923000106/elv-20231004.htm
  HTML page:      https://secwatch.observer/filing/0001156039-23-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer